Visit our Christmas Gift Finder
Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents - JSS Research Series in Statistics (Paperback)
  • Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents - JSS Research Series in Statistics (Paperback)
zoom

Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents - JSS Research Series in Statistics (Paperback)

(author), (author), (author), (author)
£44.99
Paperback 89 Pages / Published: 15/02/2018
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
This book deals with advanced methods for adaptive phase I dose-finding clinical trials for combination of two agents and molecularly targeted agents (MTAs) in oncology. It provides not only methodological aspects of the dose-finding methods, but also software implementations and practical considerations in applying these complex methods to real cancer clinical trials. Thus, the book aims to furnish researchers in biostatistics and statistical science with a good summary of recent developments of adaptive dose-finding methods as well as providing practitioners in biostatistics and clinical investigators with advanced materials for designing, conducting, monitoring, and analyzing adaptive dose-finding trials. The topics in the book are mainly related to cancer clinical trials, but many of those topics are potentially applicable or can be extended to trials for other diseases. The focus is mainly on model-based dose-finding methods for two kinds of phase I trials. One is clinical trials with combinations of two agents. Development of dose-finding methods for two-agent combination trials requires reasonable models that can adequately capture joint toxicity probabilities for two agents, taking into consideration possible interactions of the two agents on toxicity probability such as synergistic or antagonistic effects. Another is clinical trials for evaluating both efficacy and toxicity outcomes in single- and two-agent combination trials. These methods are often applied to the phase I trials including MTAs because the toxicity and efficacy for a MTA does not monotonically increase with dose, but the efficacy often increases initially with the dose and then plateaus. Successful software implementations for several dose-finding methods are introduced in the book, and their operating characteristics in practice are discussed. Recent advance of the adaptive dose-finding methods in drug developments are also provided.

Publisher: Springer Verlag, Japan
ISBN: 9784431555728
Number of pages: 89
Weight: 175 g
Dimensions: 235 x 155 mm
Edition: 1st ed. 2018

You may also be interested in...

Research Methods in Clinical Psychology
Added to basket
How to Write a Grant Application
Added to basket
ECG Pocket
Added to basket
£8.99
Paperback
Pocket Guide to Biomolecular NMR
Added to basket
Stem Cells: A Very Short Introduction
Added to basket
Oxford Handbook of Clinical Examination and Practical Skills
Added to basket
Cardiac Electrophysiology and Catheter Ablation
Added to basket
Great Medical Discoveries
Added to basket
The Immortal Life of Henrietta Lacks
Added to basket
The Cancer Chronicles
Added to basket
How to Read a Paper
Added to basket
Nutrition Research Methodologies
Added to basket
Testing Treatments
Added to basket
£9.99
Paperback

Please sign in to write a review

Your review has been submitted successfully.